Carregant...
Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
Bronchodilators, including long-acting β(2)-agonists and long-acting muscarinic antagonists, are the mainstay for treatment of patients with chronic obstructive pulmonary disease (COPD) to prevent exacerbations or reduce symptoms. Formoterol is a highly selective and potent β(2)-agonist that relaxes...
Guardat en:
| Publicat a: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7708267/ https://ncbi.nlm.nih.gov/pubmed/33273813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S273497 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|